IMMUNOHISTOCHEMICAL EXPRESSION OF GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
Objective: To determine the frequency of immunohistochemically expression of Glypican-3 in hepatocellular carcinoma on liver biopsies. Study Design: Descriptive cross-sectional study. Place and Duration of Study: Department of Histopathology, Armed Forces Institute of Pathology (AFIP), Rawalpindi,...
Guardado en:
Autores principales: | Dr Syed Salman Ali, Javeria Shaukat, Rabia Ahmed, Iqbal Muhammad |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Army Medical College Rawalpindi
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9152dd23a334495089479df1201b436e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study
por: Hamid Hashemi Yeganeh, et al.
Publicado: (2021) -
A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma
por: Zhao M, et al.
Publicado: (2018) -
Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
por: Ai,Xuejun, et al.
Publicado: (2018) -
Glypican-1-antibody-conjugated Gd-Au nanoclusters for FI/MRI dual-modal targeted detection of pancreatic cancer
por: Huang X, et al.
Publicado: (2018) -
NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
por: Wang Jianlong, et al.
Publicado: (2021)